HCA Healthcare, headquartered in Nashville, TN, is the largest non-governmental operator of acute care hospitals in the United States. As of late 2025, the company operated 190 hospitals and approximately 2,500 ambulatory sites across 19 American states and the United Kingdom. The business is organized into three geographic groups: National, Atlantic, and American, with an additional Corporate and Other group managing facilities in England. Financially, HCA generated revenues of $75.6 billion in 2025. Analysts forecast total revenues to reach between $77 billion and $79.5 billion in 2026, driven by higher admissions and strategic acquisitions that expand the network and strengthen market presence. Same-facility admissions increased 1.7% year over year in the first six months of 2026. The company maintains disciplined capital deployment, returning $4 billion to shareholders through share repurchases and dividends during the first half of 2026. However, persistently rising expenses continue to pressure margins, and the company faces regulatory headwinds under the current administration alongside a substantial debt burden resulting in high interest costs. Shares have rallied 6.79% over the past four weeks, with consensus estimates moving up following one higher earnings estimate revision in the past two months for fiscal 2026. Despite these positive momentum indicators and revenue growth, analysts reiterate a Neutral recommendation on the stock due to margin pressures and regulatory risks.